Genetics in Sarcoidosis and Its Burden as a Multisystem Disease

Area of Science:

• Immunology
• Genetics
• Pulmonary Medicine

Background:

• Sarcoidosis is a complex immune-mediated disease with varied clinical presentations and outcomes, including pulmonary fibrosis.
• Its pathogenesis is poorly understood due to heterogeneity and lack of preclinical models.
• Risk factors include demographics and environmental exposures, leading to granuloma formation and fibrosis.

Purpose of the Study:

• To review the current understanding of the genetic and genomic landscape of sarcoidosis.
• To identify key genetic loci and biological pathways involved in sarcoidosis susceptibility and progression.
• To highlight the importance of genetic factors in disease pathogenesis and therapeutic development.

Main Methods:

• Literature review synthesizing current knowledge on sarcoidosis genetics and genomics.
• Analysis of established risk factors and their role in disease mechanisms.
• Examination of immune dysregulation and genetic susceptibility in sarcoidosis.

Main Results:

• Sarcoidosis exhibits significant clinical and molecular heterogeneity (endophenotypes).
• Genetic susceptibility and immune dysfunction are central to disease pathogenesis.
• Inflammatory pathways promote fibroblast activity, leading to lung remodeling and fibrosis.

Conclusions:

• Understanding sarcoidosis genetics is crucial for identifying molecular drivers.
• Genetic insights can lead to biomarkers for early diagnosis and prognosis.
• Targeted therapies based on genetic understanding hold promise for sarcoidosis treatment.